Episode Details
Back to Episodes
Bowel Cancer Linked to Diet, Ibrance Extends Breast Cancer Survival, Timing Cancer Treatment Boosts Survival, Study Links Brain Atrophy to Schizophrenia, and more...
Published 1 year, 4 months ago
Description
(0:10): Early-Onset Bowel Cancer Surge: Ultra-Processed Foods and Lifestyle Choices Under Spotlight
(2:40): Pfizer's Ibrance Shows Promise in HR+, HER2+ Breast Cancer Trial, Extending Survival by 15 Months
(5:31): Timing Cancer Treatment with Circadian Rhythms Boosts Glioblastoma Survival, Study Finds
(7:43): New Study Links Brain Atrophy Pattern to Schizophrenia, Sparks Debate on Neurodegenerative Classification
(9:25): NASA Unveils Ambitious 20-Year Mars Exploration Plan, Excludes Sample Return Program
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Medical Xpress
(2:40): Pfizer's Ibrance Shows Promise in HR+, HER2+ Breast Cancer Trial, Extending Survival by 15 Months
(5:31): Timing Cancer Treatment with Circadian Rhythms Boosts Glioblastoma Survival, Study Finds
(7:43): New Study Links Brain Atrophy Pattern to Schizophrenia, Sparks Debate on Neurodegenerative Classification
(9:25): NASA Unveils Ambitious 20-Year Mars Exploration Plan, Excludes Sample Return Program
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Medical Xpress